Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

James Suen

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arteriovenous Malformations
9
2018
67
1.630
 Why?
Head and Neck Neoplasms
14
2012
268
1.370
 Why?
Carcinoma, Squamous Cell
12
2011
318
0.920
 Why?
Neck
7
2018
99
0.740
 Why?
Vascular Malformations
3
2010
98
0.690
 Why?
Head
5
2018
73
0.660
 Why?
Patients
1
2018
49
0.610
 Why?
Terminal Care
1
2018
45
0.600
 Why?
Hemangioma
3
2018
83
0.580
 Why?
Laryngectomy
3
2013
28
0.560
 Why?
Attitude to Health
1
2018
192
0.560
 Why?
Flow Cytometry
7
2024
476
0.560
 Why?
Laryngeal Neoplasms
2
2007
42
0.530
 Why?
Quality of Life
3
2012
836
0.490
 Why?
Carcinoma, Merkel Cell
4
2016
41
0.490
 Why?
Laser Therapy
3
2011
84
0.480
 Why?
Laryngeal Diseases
1
2013
12
0.430
 Why?
Herpes Simplex
1
2013
21
0.430
 Why?
Parotid Diseases
1
2012
3
0.430
 Why?
Neuromuscular Agents
1
2012
7
0.430
 Why?
Nuclear Proteins
6
2015
242
0.430
 Why?
Botulinum Toxins, Type A
1
2012
13
0.420
 Why?
Leukoplakia, Oral
1
2011
6
0.400
 Why?
Aminolevulinic Acid
1
2011
8
0.400
 Why?
Lasers, Dye
1
2011
9
0.400
 Why?
Eating
1
2012
162
0.400
 Why?
Photosensitizing Agents
1
2011
21
0.400
 Why?
Photochemotherapy
1
2011
34
0.390
 Why?
Survivors
1
2012
126
0.390
 Why?
Female
30
2024
26472
0.380
 Why?
Humans
49
2024
49974
0.370
 Why?
Middle Aged
21
2024
12069
0.370
 Why?
Male
30
2024
25241
0.360
 Why?
Photoacoustic Techniques
2
2024
72
0.360
 Why?
Cheek
1
2010
9
0.360
 Why?
Lip
1
2010
11
0.350
 Why?
Neoplastic Cells, Circulating
4
2019
74
0.350
 Why?
Facial Neoplasms
1
2010
22
0.350
 Why?
Pain
1
2012
379
0.340
 Why?
Adult
21
2024
13236
0.340
 Why?
Aged
16
2018
9310
0.340
 Why?
Receptors, Progesterone
1
2009
63
0.340
 Why?
Postoperative Complications
3
2012
984
0.340
 Why?
Lymphatic Vessels
1
2009
48
0.330
 Why?
Skin Neoplasms
4
2016
488
0.320
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
989
0.310
 Why?
Neoplasms
1
2018
1235
0.310
 Why?
Recurrent Laryngeal Nerve
1
2007
13
0.310
 Why?
Laryngeal Nerves
1
2007
16
0.310
 Why?
Surgical Flaps
1
2009
119
0.300
 Why?
Factor VII
1
2007
3
0.290
 Why?
Melanoma
2
2022
285
0.290
 Why?
Erythrocytes
2
2024
83
0.290
 Why?
Intracranial Arteriovenous Malformations
1
2007
29
0.290
 Why?
Dilatation
2
2017
26
0.280
 Why?
Malaria
2
2024
37
0.260
 Why?
Adolescent
11
2024
6356
0.250
 Why?
Gene Silencing
4
2009
119
0.250
 Why?
Disease Models, Animal
3
2016
1455
0.240
 Why?
Cell Proliferation
4
2016
1007
0.220
 Why?
Retrospective Studies
10
2015
6108
0.220
 Why?
Melanoma, Experimental
2
2016
45
0.220
 Why?
Immunohistochemistry
8
2014
973
0.210
 Why?
Treatment Outcome
7
2018
5141
0.210
 Why?
Muscarinic Agonists
1
2002
10
0.210
 Why?
Xerostomia
1
2002
3
0.210
 Why?
Sjogren's Syndrome
1
2002
9
0.210
 Why?
Promoter Regions, Genetic
7
2015
475
0.210
 Why?
Endoscopy
2
2015
124
0.210
 Why?
Thiophenes
1
2002
36
0.210
 Why?
Plasmodium yoelii
1
2022
14
0.200
 Why?
Nitric Oxide Synthase Type III
2
2013
78
0.200
 Why?
Quinuclidines
1
2002
40
0.200
 Why?
Veins
3
2010
71
0.190
 Why?
Transcription Factors
2
2015
561
0.190
 Why?
Embolization, Therapeutic
3
2011
88
0.190
 Why?
Azepines
3
2016
18
0.190
 Why?
Triazoles
3
2016
108
0.180
 Why?
Child
10
2012
6847
0.170
 Why?
Child, Preschool
8
2012
3871
0.170
 Why?
Neoplasm Invasiveness
3
2010
267
0.170
 Why?
Mast Cells
1
2018
52
0.160
 Why?
Mice
10
2022
5739
0.150
 Why?
Ki-67 Antigen
3
2013
57
0.150
 Why?
Combined Modality Therapy
4
2018
637
0.150
 Why?
Cricoid Cartilage
1
2017
11
0.150
 Why?
Trachea
1
2017
52
0.140
 Why?
Estradiol
1
2018
225
0.140
 Why?
Mice, Nude
5
2016
252
0.140
 Why?
Follow-Up Studies
3
2011
2182
0.140
 Why?
Biopsy
3
2015
584
0.140
 Why?
Infant
7
2018
3567
0.140
 Why?
Lasers, Semiconductor
2
2022
10
0.140
 Why?
Embolism
1
2016
20
0.140
 Why?
Benzoxazoles
1
2016
11
0.130
 Why?
Neoplasm Staging
2
2010
740
0.130
 Why?
Matrix Metalloproteinase 2
1
2016
57
0.130
 Why?
Qualitative Research
1
2018
329
0.130
 Why?
Matrix Metalloproteinase 9
1
2016
88
0.130
 Why?
Tracheotomy
1
2015
13
0.130
 Why?
TOR Serine-Threonine Kinases
1
2016
77
0.130
 Why?
Tracheal Stenosis
1
2015
12
0.130
 Why?
Laryngostenosis
1
2015
11
0.130
 Why?
Aged, 80 and over
6
2015
3129
0.130
 Why?
Proto-Oncogene Proteins c-myb
1
2015
8
0.130
 Why?
Larynx
2
2017
30
0.130
 Why?
Pyrimidines
1
2016
192
0.120
 Why?
Proto-Oncogene Proteins c-myc
1
2014
50
0.120
 Why?
Disease Progression
3
2014
825
0.120
 Why?
Fluorouracil
2
2004
54
0.120
 Why?
Gene Expression Regulation, Neoplastic
3
2015
828
0.120
 Why?
Carcinoma
2
2012
138
0.120
 Why?
DNA Methylation
5
2009
548
0.120
 Why?
Plasmodium falciparum
2
2024
18
0.110
 Why?
Breast Neoplasms
2
2015
1174
0.110
 Why?
Apoptosis
2
2016
1101
0.110
 Why?
Animals
10
2022
13187
0.110
 Why?
Mastication
1
2012
5
0.110
 Why?
Trismus
1
2012
3
0.110
 Why?
DNA, Neoplasm
2
2011
147
0.100
 Why?
Radiotherapy, Adjuvant
1
2012
56
0.100
 Why?
Adaptor Proteins, Signal Transducing
3
2009
197
0.100
 Why?
Cisplatin
2
2004
278
0.100
 Why?
Recurrence
2
2011
652
0.100
 Why?
Receptors, Cell Surface
1
2013
122
0.100
 Why?
Lymphangioma, Cystic
1
2011
10
0.100
 Why?
Chemoradiotherapy
1
2012
40
0.100
 Why?
Cross-Sectional Studies
3
2024
1557
0.100
 Why?
Endothelium, Lymphatic
1
2011
12
0.100
 Why?
Syndrome
1
2012
237
0.100
 Why?
Administration, Topical
1
2011
56
0.100
 Why?
Epigenesis, Genetic
1
2015
374
0.100
 Why?
Antigens, CD
1
2013
219
0.100
 Why?
Lymphatic Abnormalities
1
2011
22
0.100
 Why?
Propranolol
1
2012
78
0.100
 Why?
Immunoenzyme Techniques
4
2016
143
0.100
 Why?
Enteral Nutrition
1
2012
147
0.100
 Why?
Microtubule-Associated Proteins
1
2011
67
0.100
 Why?
Deglutition Disorders
1
2012
77
0.100
 Why?
Homeodomain Proteins
1
2011
80
0.100
 Why?
Brain Neoplasms
1
2014
287
0.090
 Why?
Tumor Suppressor Proteins
1
2011
128
0.090
 Why?
Diagnosis, Differential
2
2011
1037
0.090
 Why?
Risk Assessment
1
2015
1259
0.090
 Why?
Epigenomics
1
2011
67
0.090
 Why?
Weight Gain
1
2012
240
0.090
 Why?
Xenograft Model Antitumor Assays
3
2016
211
0.090
 Why?
Lip Neoplasms
1
2010
3
0.090
 Why?
Neoplasm Proteins
2
2003
322
0.090
 Why?
Diagnostic Imaging
1
2011
176
0.090
 Why?
Neoplasm Recurrence, Local
2
2019
614
0.090
 Why?
Neoplastic Stem Cells
1
2011
103
0.090
 Why?
Neoadjuvant Therapy
1
2011
114
0.090
 Why?
Hospitals, Teaching
1
2010
53
0.090
 Why?
Survival Rate
3
2011
894
0.090
 Why?
Lasers, Solid-State
1
2010
32
0.090
 Why?
Microsatellite Instability
1
2009
17
0.090
 Why?
Melanins
1
2009
27
0.090
 Why?
Young Adult
3
2024
3958
0.090
 Why?
Medical Records
1
2010
83
0.090
 Why?
Mouth
1
2010
33
0.090
 Why?
Vascular Surgical Procedures
1
2011
165
0.090
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.090
 Why?
Carcinoma, Medullary
1
2009
12
0.090
 Why?
Pilot Projects
1
2011
699
0.080
 Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.080
 Why?
Receptors, Estrogen
1
2009
130
0.080
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
22
0.080
 Why?
Immunotherapy
1
2011
238
0.080
 Why?
Muscle, Smooth, Vascular
1
2009
130
0.080
 Why?
Port-Wine Stain
1
2008
14
0.080
 Why?
Blotting, Western
3
2016
601
0.080
 Why?
Dose-Response Relationship, Drug
1
2011
1376
0.080
 Why?
Early Detection of Cancer
2
2022
169
0.080
 Why?
Thyroid Neoplasms
1
2009
110
0.080
 Why?
Cytokines
1
2011
612
0.080
 Why?
Vascular Endothelial Growth Factor A
1
2008
201
0.080
 Why?
Tumor Cells, Cultured
3
2016
465
0.070
 Why?
Practice Guidelines as Topic
1
2010
449
0.070
 Why?
Factor VIIa
1
2007
9
0.070
 Why?
Jaw Diseases
1
2007
6
0.070
 Why?
Infant, Newborn
2
2011
2772
0.070
 Why?
Practice Management, Medical
1
2006
12
0.070
 Why?
Osteonecrosis
1
2007
34
0.070
 Why?
Postoperative Hemorrhage
1
2007
51
0.070
 Why?
Tongue
1
2007
39
0.070
 Why?
Bone Density Conservation Agents
1
2007
77
0.070
 Why?
Otolaryngology
1
2006
55
0.070
 Why?
Diphosphonates
1
2007
90
0.070
 Why?
Cell Line, Tumor
3
2015
1403
0.070
 Why?
Recombinant Proteins
1
2007
486
0.060
 Why?
Prospective Studies
1
2011
2364
0.060
 Why?
Skin
1
2008
409
0.060
 Why?
Mice, Inbred NOD
2
2016
96
0.060
 Why?
Cameroon
1
2024
4
0.060
 Why?
Mice, SCID
2
2016
175
0.060
 Why?
Hemeproteins
1
2024
8
0.060
 Why?
Parasitemia
1
2024
8
0.060
 Why?
Malaria, Falciparum
1
2024
13
0.060
 Why?
Neoplasm Metastasis
2
2015
231
0.060
 Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2004
9
0.060
 Why?
DNA Repair Enzymes
1
2004
44
0.060
 Why?
Ataxia Telangiectasia
1
2004
6
0.060
 Why?
ROC Curve
1
2024
232
0.060
 Why?
Statistics, Nonparametric
1
2004
194
0.060
 Why?
Polymerase Chain Reaction
4
2009
453
0.060
 Why?
Genes, p16
1
2003
9
0.060
 Why?
Lymph Node Excision
1
2004
134
0.060
 Why?
Radiotherapy
1
2004
128
0.060
 Why?
Proteoglycans
1
2003
80
0.060
 Why?
Magnetic Resonance Angiography
2
2018
77
0.050
 Why?
Antigens, Nuclear
2
2013
24
0.050
 Why?
Magnetic Resonance Imaging
2
2007
1537
0.050
 Why?
Transplantation, Heterologous
2
2013
74
0.050
 Why?
Longitudinal Studies
1
2024
688
0.050
 Why?
Sensitivity and Specificity
1
2024
861
0.050
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
595
0.050
 Why?
Membrane Glycoproteins
1
2003
240
0.050
 Why?
Double-Blind Method
1
2002
681
0.050
 Why?
Survival Analysis
3
2009
653
0.040
 Why?
Tryptases
1
2018
4
0.040
 Why?
Estrogen Receptor beta
1
2018
54
0.040
 Why?
Arkansas
1
2004
1977
0.040
 Why?
Estrogen Receptor alpha
1
2018
89
0.040
 Why?
Protein Transport
1
2018
180
0.040
 Why?
Ultrasonography, Doppler
1
2018
42
0.040
 Why?
Biopsy, Fine-Needle
2
2009
103
0.040
 Why?
Cadaver
1
2017
97
0.040
 Why?
Pressure
1
2017
105
0.040
 Why?
Serum
1
2016
32
0.030
 Why?
Risk Factors
3
2015
3613
0.030
 Why?
Molecular Imaging
1
2016
53
0.030
 Why?
Drug Synergism
1
2016
150
0.030
 Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
17
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2016
181
0.030
 Why?
Acetylation
1
2015
97
0.030
 Why?
Enhancer Elements, Genetic
1
2015
61
0.030
 Why?
Mammography
1
2015
96
0.030
 Why?
Keratin-20
1
2014
7
0.030
 Why?
G1 Phase Cell Cycle Checkpoints
1
2014
17
0.030
 Why?
Drug Therapy, Combination
1
2016
377
0.030
 Why?
Prognosis
3
2004
1942
0.030
 Why?
Chromatin
1
2015
151
0.030
 Why?
Cell Cycle Proteins
1
2015
166
0.030
 Why?
HEK293 Cells
1
2014
222
0.030
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2013
32
0.030
 Why?
Gene Expression Regulation
1
2018
976
0.030
 Why?
Comorbidity
1
2015
615
0.030
 Why?
Protein Binding
1
2015
660
0.030
 Why?
Down-Regulation
1
2014
348
0.030
 Why?
Actins
1
2013
118
0.030
 Why?
RNA, Messenger
1
2016
1105
0.030
 Why?
Base Sequence
2
2004
643
0.030
 Why?
Lymphocele
1
2011
7
0.030
 Why?
Tissue Survival
1
2011
10
0.030
 Why?
Predictive Value of Tests
1
2014
903
0.030
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
47
0.020
 Why?
Tissue Culture Techniques
1
2011
40
0.020
 Why?
Cell Line
1
2014
1000
0.020
 Why?
Neoplasms, Squamous Cell
1
2011
7
0.020
 Why?
Gluconates
1
2011
1
0.020
 Why?
Gene Expression Profiling
1
2016
1032
0.020
 Why?
Graft Survival
1
2011
150
0.020
 Why?
Indomethacin
1
2011
38
0.020
 Why?
Injections, Subcutaneous
1
2011
54
0.020
 Why?
Interleukin-2
1
2011
72
0.020
 Why?
Carrier Proteins
2
2003
304
0.020
 Why?
Time Factors
2
2007
2903
0.020
 Why?
Interleukin-1beta
1
2011
75
0.020
 Why?
Cyclophosphamide
1
2011
165
0.020
 Why?
Interferon-gamma
1
2011
177
0.020
 Why?
Drug Administration Schedule
1
2011
376
0.020
 Why?
Glottis
1
2010
32
0.020
 Why?
Disease-Free Survival
1
2011
454
0.020
 Why?
Endothelial Cells
1
2011
269
0.020
 Why?
Sclerotherapy
1
2010
45
0.020
 Why?
Calcitonin
1
2009
30
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2011
388
0.020
 Why?
Thyroidectomy
1
2009
59
0.020
 Why?
Paraffin Embedding
1
2008
53
0.020
 Why?
Mice, Transgenic
1
2009
555
0.020
 Why?
Signal Transduction
1
2014
1618
0.020
 Why?
Curettage
1
2007
13
0.020
 Why?
Dental Care
1
2007
11
0.020
 Why?
Mouth Floor
1
2007
5
0.020
 Why?
Polyvinyl Alcohol
1
2007
9
0.020
 Why?
Hyperbaric Oxygenation
1
2007
14
0.020
 Why?
Current Procedural Terminology
1
2006
7
0.020
 Why?
Collateral Circulation
1
2007
39
0.020
 Why?
Pharyngeal Diseases
1
2007
14
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Cutaneous Fistula
1
2007
15
0.020
 Why?
Neck Dissection
1
2007
31
0.020
 Why?
Office Visits
1
2006
41
0.020
 Why?
Angiography
1
2007
126
0.020
 Why?
Fistula
1
2007
24
0.020
 Why?
Adrenal Cortex Hormones
1
2007
94
0.020
 Why?
Salvage Therapy
1
2007
139
0.020
 Why?
Genetic Predisposition to Disease
1
2009
510
0.020
 Why?
Imidazoles
1
2007
119
0.020
 Why?
Preoperative Care
1
2007
164
0.020
 Why?
Ultrasonography
1
2006
436
0.020
 Why?
United States
1
2015
4860
0.020
 Why?
Guanine
1
2004
40
0.010
 Why?
DNA Adducts
1
2004
78
0.010
 Why?
Syndecans
1
2003
34
0.010
 Why?
Methylation
1
2004
122
0.010
 Why?
Syndecan-1
1
2003
72
0.010
 Why?
Base Pair Mismatch
1
2003
22
0.010
 Why?
Cell Count
1
2003
147
0.010
 Why?
Antineoplastic Agents
1
2011
1171
0.010
 Why?
DNA Repair
1
2003
193
0.010
 Why?
Alcohol Drinking
1
2003
224
0.010
 Why?
Molecular Sequence Data
1
2003
792
0.010
 Why?
Anti-Bacterial Agents
1
2007
744
0.010
 Why?
Smoking
1
2003
511
0.010
 Why?
Multiple Myeloma
1
2007
2929
0.010
 Why?
Suen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (317) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (30) people
_
Same Department Expand Description
Search Department